Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions; Second Edition; Guidance for Industry; Availability

Summary

The Food and Drug Administration (FDA) is releasing a second edition of its guidance for the tobacco industry, providing more information on demonstrating substantial equivalence for new tobacco products. This includes scenarios where a new product has a modified label or identical composition to an existing valid product.